Core Laboratories (CLB) Misses Q1 EPS by 29c, provides guidance

Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.00, $0.29 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $123.6 million versus the consensus estimate of $143.5 million.

GUIDANCE:

Core Laboratories sees Q2 2025 revenue of $128-134 million, versus the consensus of $128.9 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Leidos wins $85m Air Force contract for aerospace design
• SmartKem (SMTK) files for 15.13M share offering by selling stockholders